Dennis Cantellops Paite
FDA investigator
Appears on 2 documents from 2015 to 2023, mostly at sites in China. Most often cites general requirements (21 CFR 211.160).
- 2
- Documents on file
- 7.5
- Observations per 483
- 2015
- First seen
- 2023
- Most recent
What they cite most
From 15 observations- 21 CFR 211.160General requirements4
- 21 CFR 820.30(b)Design controls2
- 21 CFR 211.134(c)Drug product inspection1
- 21 CFR 211.188Batch production and control records1
- 21 CFR 211.22(d)Responsibilities of quality control unit1
- 21 CFR 211.67(b)(1)Equipment cleaning and maintenance1
Activity by year
2015: 1, 2023: 1
Where
China 1 · Puerto Rico 1
Often inspects with
Is Dennis Cantellops Paite coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2023-11-21 | 483 Nanchang Anobri Pharmaceuticals Co., LtdNov 21, 2023 · Nanchang, China | Nanchang, China | 12 | |
| 2015-05-29 | 483 Janssen Ortho LLCMay 29, 2015 · Gurabo, Puerto Rico | Gurabo, Puerto Rico | 3 |
About this profile
What does Dennis Cantellops Paite inspect?
Dennis Cantellops Paite appears on 2 documents on file covering 2 sites, mostly in China.
What do they cite most often?
21 CFR 211.160 (general requirements), followed by 21 CFR 820.30(b) and 21 CFR 211.134(c).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Dennis Cantellops Paite is dated Nov 21, 2023.